MedTrace Logo

Allium Sativum Oil as Alternative Non-vital Pulpotomy Medicament in Primary Teeth

NCT05801367 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2023-04-06

No results posted yet for this study

Summary

The purpose of this randomized controlled clinical trial is to use Allium sativum oil as non-vital Pulpotomy medicament compared to Formocresol in primary teeth by evaluating its antibacterial effect against Streptococcus mutans and Lactobacillus acidophilus. It is hypothesized that there is no difference in the antibacterial effect of Allium sativum oil compared with Formocresol, when used as non-vital Pulpotomy medicaments.

Conditions

  • Non-Vital Tooth

Interventions

DRUG

Formocresol

Formocresol will be used as non-vital pulpotomy medicament (which is gold standard)

DRUG

Allium Sativum Oil

Allium sativum oil will be used as non-vital pulpotomy medicament compared with Formocresol (which is gold standard)

Sponsors & Collaborators

  • Lahore General Hospital

    collaborator OTHER_GOV

  • University of Health Sciences Lahore

    lead OTHER

Principal Investigators

  • Shazia Naz, BDS, MDS · Assistant professor operative dentistry de, Montmorency College of Dentistry

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
4 Years
Max Age
8 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-10-20
Primary Completion
2023-02-23
Completion
2023-03-02

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05801367 on ClinicalTrials.gov